MTM(SH:688029) Sou Hu Cai Jing·2025-05-13 10:59Core Viewpoint - Nanwei Medical's stock closed at 64.01 yuan, with a PE ratio of 21.07, marking a new low in 25 days, and a total market capitalization of 12.024 billion yuan [1] Group 1: Company Overview - Nanwei Medical specializes in the research, manufacturing, and sales of minimally invasive medical devices, including endoscopic diagnostic instruments, microwave ablation equipment, and disposable endoscopes [1] - The company is one of the major manufacturers of endoscopic diagnostic instruments in China, recognized for its early start, strong innovation capabilities, rich product lines, and significant scale advantages [1] Group 2: Financial Performance - For Q1 2025, the company reported an operating income of 699 million yuan, a year-on-year increase of 12.75%, and a net profit of 161 million yuan, also up 12.18%, with a gross profit margin of 65.69% [2] - As of Q1 2025, 17 institutions held shares in Nanwei Medical, including 11 funds, 4 other institutions, and 2 social security funds, with a total holding of 106.4733 million shares valued at 7.017 billion yuan [1] Group 3: Industry Comparison - The average PE ratio for the medical device industry is 50.06, with a median of 36.80, positioning Nanwei Medical at 49th place within the industry [1][2] - The company's current PE ratio is significantly lower than the industry average, indicating potential undervaluation compared to peers [2]